:. Jennette, J. C. Falk, R. J. Bacon, P. A. Basu, N. Cid et al., revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides, vol.65, pp.1-11, 2012.

R. Kalluri, C. B. Wilson, M. Weber, S. Gunwar, A. M. Chonko et al., Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome, J. Am. Soc. Nephrol, vol.6, pp.1178-1185, 1995.

T. Hellmark, H. Burkhardt, J. Wieslander, and . Goodpasture-disease, Characterization of a single conformational epitope as the target of pathogenic autoantibodies, J. Biol. Chem, vol.274, pp.25862-25868, 1999.

C. O. Savage, C. D. Pusey, C. Bowman, A. J. Rees, and C. M. Lockwood, Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4, Br. Med. J. Clin. Res. Ed, vol.292, pp.301-304, 1986.

E. G. Fischer and D. J. Lager, Anti-glomerular basement membrane glomerulonephritis: A morphologic study of 80 cases, Am. J. Clin. Pathol, vol.125, pp.445-450, 2006.

A. Rutgers, M. Slot, P. Van-paassen, P. Van-breda-vriesman, P. Heeringa et al., Coexistence of Anti-Glomerular Basement Membrane Antibodies and Myeloperoxidase-ANCAs in Crescentic Glomerulonephritis, Am. J. Kidney Dis, vol.46, pp.253-262, 2005.

J. Lindic, A. Vizjak, D. Ferluga, D. Kovac, A. Ales et al., Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane, Ther. Apher. Dial, vol.13, pp.278-281, 2009.

S. P. Mcadoo, A. Tanna, Z. Hru?ková, L. Holm, M. Weiner et al., Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients, Kidney Int, vol.92, pp.693-702, 2017.

S. B. Erickson, S. B. Kurtz, J. V. Donadio, K. E. Holley, C. B. Wilson et al., Use of combined plasmapheresis and immunosuppression in the treatment of Goodpasture's syndrome, Mayo Clin. Proc, vol.54, pp.714-720, 1979.

J. P. Johnson, J. Moore, H. A. Austin, J. E. Balow, T. T. Antonovych et al., Therapy of anti-glomerular basement membrane antibody disease: Analysis of prognostic significance of clinical, pathologic and treatment factors, Medicine, vol.64, pp.219-227, 1985.

J. B. Levy, A. N. Turner, A. J. Rees, and C. D. Pusey, Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression, Ann. Intern. Med, vol.134, pp.1033-1042, 2001.

M. Touzot, J. Poisson, S. Faguer, D. Ribes, P. Cohen et al., Rituximab in anti-GBM disease: A retrospective study of 8 patients, J. Autoimmun, vol.60, pp.74-79, 2015.

M. Heitz, P. L. Carron, G. Clavarino, T. Jouve, N. Pinel et al., Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease, BMC Nephrol, vol.19, p.241, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02180322

B. Alchi, M. Griffiths, M. Sivalingam, D. Jayne, and K. Farrington, Predictors of renal and patient outcomes in anti-GBM disease: Clinicopathologic analysis of a two-centre cohort, Nephrol. Dial. Transpl, vol.30, pp.814-821, 2015.

E. E. Van-daalen, J. C. Jennette, S. P. Mcadoo, C. D. Pusey, M. A. Alba et al., Predicting Outcome in Patients with Anti-GBM Glomerulonephritis, Clin. J. Am. Soc. Nephrol, vol.13, pp.63-72, 2018.

A. Huart, A. Josse, D. Chauveau, J. Korach, F. Heshmati et al., Outcomes of patients with Goodpasture syndrome: A nationwide cohort-based study from the French Society of Hemapheresis, J. Autoimmun, vol.73, pp.24-29, 2016.

M. E. Charlson, P. Pompei, K. L. Ales, and C. R. Mackenzie, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation, J. Chronic Dis, vol.40, pp.373-383, 1987.

A. E. Berden, F. Ferrario, E. C. Hagen, D. R. Jayne, J. C. Jennette et al., Histopathologic classification of ANCA-associated glomerulonephritis, J. Am. Soc. Nephrol, vol.21, pp.1628-1636, 2010.

J. Cordier and V. Cottin, Alveolar hemorrhage in vasculitis: Primary and secondary, Semin. Respir. Crit. Care Med, vol.32, pp.310-321, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02650780

R. A. Finch, E. A. Rutsky, E. Mcgowan, and C. B. Wilson, Treatment of Goodpasture's syndrome with immunosuppression and plasmapheresis, South. Med. J, vol.72, pp.1288-1290, 1979.

F. L. Benoit, D. B. Rulon, G. B. Theil, P. D. Doolan, and R. H. Watten, Goodpasture's Syndrome: A Clinicopathologic Entity, Am. J. Med, vol.37, pp.424-444, 1964.

A. J. Proskey, L. Weatherbee, R. E. Easterling, J. A. Greene, and J. M. Weller, Goodpasture's syndrome. A report of five cases and review of the literature, Am. J. Med, vol.48, pp.162-173, 1970.

Q. Gu, L. Xie, X. Jia, R. Ma, Y. Liao et al., Fever and prodromal infections in anti-glomerular basement membrane disease: Fever and infections in anti-GBM disease, Nephrology, vol.23, pp.476-482, 2018.

G. Chen, Y. Dong, and Z. Ju, A clinical analysis of 32 patients with diffuse alveolar hemorrhage in diffuse connective tissue diseases, Zhonghua Nei Ke Za Zhi, vol.47, pp.362-365, 2008.

Y. Lin, W. Zheng, X. Tian, X. Zhang, F. Zhang et al., Antineutrophil cytoplasmic antibody-associated vasculitis complicated with diffuse alveolar hemorrhage: A study of 12 cases, J. Clin. Rheumatol, vol.15, pp.341-344, 2009.

M. U. Martinez-martinez, A. K. Sturbaum, J. Alcocer-varela, J. Merayo-chalico, D. Gómez-martin et al., Factors Associated with Mortality and Infections in Patients with Systemic Lupus Erythematosus with Diffuse Alveolar Hemorrhage, J. Rheumatol, vol.41, pp.1656-1661, 2014.

G. O. Perez, S. Bjornsson, A. H. Ross, J. Aamato, and N. Rothfield, A mini-epidemic of Goodpasture's syndrome clinical and immunological studies, Nephron, vol.13, pp.161-173, 1974.

P. S. Williams, A. Davenport, I. Mcdicken, D. Ashby, H. J. Goldsmith et al., Increased incidence of anti-glomerular basement membrane antibody (anti-GBM) nephritis in the Mersey Region, Q. J. Med, vol.68, pp.727-733, 1984.

J. Arends, J. Wu, J. Borillo, L. Troung, C. Zhou et al., T cell epitope mimicry in antiglomerular basement membrane disease, J. Immunol, vol.176, pp.1252-1258, 2006.

J. G. Mcgregor, R. Negrete-lopez, C. J. Poulton, J. M. Kidd, S. L. Katsanos et al., Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function, Nephrol. Dial. Transpl, vol.30, pp.171-181, 2015.

W. G. Dixon, M. Abrahamowicz, M. Beauchamp, D. W. Ray, S. Bernatsky et al., Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: A nested case-control analysis, Ann. Rheum. Dis, vol.71, pp.1128-1133, 2012.

J. G. Mcgregor, S. L. Hogan, Y. Hu, C. E. Jennette, R. J. Falk et al., Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease, Clin. J. Am. Soc. Nephrol, vol.7, pp.240-247, 2012.

J. Youssef, S. A. Novosad, and K. L. Winthrop, Infection Risk and Safety of Corticosteroid Use, Rheum. Dis. Clin. N. Am, vol.42, pp.157-176, 2016.

, Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis, Kidney Int. Suppl, vol.2, pp.139-274, 2012.

D. Titeca-beauport, A. Francois, T. Lobbedez, D. Guerrot, D. Launay et al., Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: A retrospective, multicentre study, BMC Nephrol, vol.19, p.317, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02081540

A. Kronbichler, J. Kerschbaum, S. Gopaluni, J. Tieu, F. Alberici et al., Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis, Ann. Rheum. Dis, vol.77, pp.1440-1447, 2018.

L. Harper, P. Cockwell, D. Adu, and C. O. Savage, Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis, Kidney Int, vol.59, pp.1729-1738, 2001.

A. S. Mccall, G. Bhave, V. Pedchenko, J. Hess, M. Free et al., Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes, J. Am. Soc. Nephrol, vol.29, pp.2619-2625, 2018.

S. P. Mcadoo and C. D. Pusey, Peroxidasin-a Novel Autoantigen in Anti-GBM Disease?, J. Am. Soc. Nephrol, vol.29, pp.2605-2607, 2018.

R. Shi, Z. Cao, H. Li, J. Graw, G. Zhang et al., Peroxidasin contributes to lung host defense by direct binding and killing of gram-negative bacteria, PLoS Pathog, vol.14, 2018.

J. F. Subra, C. Michelet, J. Laporte, F. Carrere, P. Reboul et al., The presence of cytoplasmic antineutrophil cytoplasmic antibodies (C-ANCA) in the course of subacute bacterial endocarditis with glomerular involvement, coincidence or association?, Clin. Nephrol, vol.49, pp.15-18, 1998.

A. M. Tiliakos and N. A. Tiliakos, Dual ANCA positivity in subacute bacterial endocarditis, J. Clin. Rheumatol, vol.14, pp.38-40, 2008.

A. Mahr, F. Batteux, S. Tubiana, C. Goulvestre, M. Wolff et al., Brief report: Prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis, Arthritis Rheumatol, vol.66, pp.1672-1677, 2014.

F. B. Kamar, T. L. Hawkins, and .. , Antineutrophil Cytoplasmic Antibody Induction due to Infection: A Patient with Infective Endocarditis and Chronic Hepatitis C. Can, J. Infect Dis. Med. Microbiol, vol.3585860, 2016.

R. Choo and D. Anantham, Role of bronchoalveolar lavage in the management of immunocompromised patients with pulmonary infiltrates, Ann. Transl. Med, vol.7, p.49, 2019.